BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36241064)

  • 1. Haemospermia in the Real- Life Setting: A New High-Risk Stratification.
    Pozzi E; Ventimiglia E; Fallara G; Capogrosso P; Belladelli F; Candela L; Raffo M; Costa A; Cignoli D; Corsini C; Cazzaniga W; Boeri L; Matloob R; Capitanio U; Montorsi F; Salonia A
    Urology; 2023 Jan; 171():146-151. PubMed ID: 36241064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
    Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
    BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aetiology, diagnosis and management of haemospermia: a review.
    Magoha GA; Magoha OB
    East Afr Med J; 2007 Dec; 84(12):589-94. PubMed ID: 18402311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical impact of Prostate Imaging-Reporting and Data System classification in patients with haemospermia undergoing multiparametric magnetic resonance imaging of the prostate.
    Kilic M; Coskun B; Vural M; Musaoglu A; Esen T; Balbay MD
    Andrologia; 2021 Jun; 53(5):e14041. PubMed ID: 33694277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transurethral resection of ejaculatory duct combined with seminal vesiculoscopy for management of persistent or recurrent hemospermia in men with ejaculatory duct obstruction.
    Ren ZJ; Yang B; Lu DL; Liu SZ; Yang LC; Wang LC; Peng ZF; Liu LR; Dong Q
    BMC Urol; 2020 Mar; 20(1):34. PubMed ID: 32293392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
    Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
    Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction.
    Salonia A; Bettocchi C; Boeri L; Capogrosso P; Carvalho J; Cilesiz NC; Cocci A; Corona G; Dimitropoulos K; Gül M; Hatzichristodoulou G; Jones TH; Kadioglu A; Martínez Salamanca JI; Milenkovic U; Modgil V; Russo GI; Serefoglu EC; Tharakan T; Verze P; Minhas S;
    Eur Urol; 2021 Sep; 80(3):333-357. PubMed ID: 34183196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool.
    De Nunzio C; Leonardo C; Franco G; Esperto F; Brassetti A; Simonelli G; Dente D; De Dominicis C; Tubaro A
    World J Urol; 2013 Apr; 31(2):365-9. PubMed ID: 22576696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Jan; 65(1):124-37. PubMed ID: 24207135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
    Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma.
    Katayama S; Mori K; Schuettfort VM; Pradere B; Mostafaei H; Quhal F; Rajwa P; Motlagh RS; Laukhtina E; Moschini M; Grossmann NC; Araki M; Teoh JY; Rouprêt M; Margulis V; Enikeev D; Karakiewicz PI; Abufaraj M; Compérat E; Nasu Y; Shariat SF
    Eur Urol Focus; 2022 May; 8(3):761-768. PubMed ID: 34053904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory haemospermia: any predictive factors?
    Amano T; Kunimi K; Tokunaga S; Ohkawa M
    Int Urol Nephrol; 1995; 27(3):335-9. PubMed ID: 7591600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups.
    Mazzone E; Gandaglia G; Ploussard G; Marra G; Valerio M; Campi R; Mari A; Minervini A; Serni S; Moschini M; Marquis A; Beauval JB; van den Bergh R; Rahota RG; Soeterik T; Roumiguiè M; Afferi L; Zhuang J; Guo H; Mattei A; Gontero P; Cucchiara V; Stabile A; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2022 Feb; 81(2):193-203. PubMed ID: 34399996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer.
    Rieken M; Shariat SF; Kluth L; Crivelli JJ; Abufaraj M; Foerster B; Mari A; Ilijazi D; Karakiewicz PI; Babjuk M; Gönen M; Xylinas E
    Urol Oncol; 2018 Jan; 36(1):8.e17-8.e24. PubMed ID: 28947304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification.
    Draulans C; Everaerts W; Isebaert S; Gevaert T; Oyen R; Joniau S; Lerut E; De Wever L; Weynand B; Vanhoutte E; De Meerleer G; Haustermans K
    Urology; 2019 Aug; 130():113-119. PubMed ID: 31051166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
    Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
    Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemospermia: how to proceed?
    Creagh T; McNamara A; McDermott TE; Grainger R; Butler M
    Ir J Med Sci; 1993 May; 162(5):173-4. PubMed ID: 8335452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haemospermia: presentation of a case].
    Garrastazu-Lopez R; Lomba-Falcon JM
    Semergen; 2012; 38(5):335-9. PubMed ID: 23544781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematospermia - a systematic review.
    Kumar P; Kapoor S; Nargund V
    Ann R Coll Surg Engl; 2006 Jul; 88(4):339-42. PubMed ID: 16834849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.